BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36598325)

  • 21. Clinical impact and functional aspects of tenascin-C expression during glioma progression.
    Herold-Mende C; Mueller MM; Bonsanto MM; Schmitt HP; Kunze S; Steiner HH
    Int J Cancer; 2002 Mar; 98(3):362-9. PubMed ID: 11920587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population.
    Howard EM; Lau SK; Lyles RH; Birdsong GG; Tadros TS; Umbreit JN; Kochhar R
    Int J Clin Oncol; 2004 Jun; 9(3):154-60. PubMed ID: 15221598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin expression and serum levels in pancreatic cancer.
    Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
    World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of VE-cadherin increase independently of VEGF in preoperative sera of patients with colorectal cancer.
    Sulkowska M; Famulski W; Wincewicz A; Moniuszko T; Kedra B; Koda M; Zalewski B; Baltaziak M; Sulkowski S
    Tumori; 2006; 92(1):67-71. PubMed ID: 16683386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.
    Gebauer F; Gelis S; Zander H; Meyer KF; Wolters-Eisfeld G; Izbicki JR; Bockhorn M; Tachezy M
    Oncotarget; 2016 Apr; 7(15):20945-52. PubMed ID: 26967391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis.
    Luo KJ; Hu Y; Wen J; Fu JH
    J Surg Oncol; 2011 Sep; 104(3):236-43. PubMed ID: 21480261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of survivin and vascular endothelial growth factor mRNA detection in the peripheral whole blood of breast cancer patients.
    Wang S; Xu J; Zhang Q
    Neoplasma; 2016; 63(1):133-40. PubMed ID: 26639243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme.
    Musumeci G; Magro G; Cardile V; Coco M; Marzagalli R; Castrogiovanni P; Imbesi R; Graziano AC; Barone F; Di Rosa M; Castorina S; Castorina A
    Cell Tissue Res; 2015 Oct; 362(1):45-60. PubMed ID: 25948484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
    Gao M; Zhang X; Li D; He P; Tian W; Zeng B
    Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of multi-parameter diffusion and perfusion magnetic resonance imaging for evaluating epithelial-mesenchymal transition in rectal cancer.
    Chen Y; Jiang Z; Guan X; Li H; Li C; Tang C; Lei Y; Dang Y; Song B; Long L
    Eur J Radiol; 2022 May; 150():110245. PubMed ID: 35299114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
    Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
    Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer.
    Stec R; Cierniak S; Lubas A; Brzóskowska U; Syryło T; Zieliński H; Semeniuk-Wojtaś A
    Pathol Oncol Res; 2020 Apr; 26(2):1211-1219. PubMed ID: 31346958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation.
    Chiu KW; Nakano T; Chen KD; Hsu LW; Lai CY; Huang CY; Cheng YF; Goto S; Chen CL
    PLoS One; 2015; 10(5):e0124943. PubMed ID: 25978323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of high levels of survivin and transforming growth factor beta-1 proteins in aqueous humor and serum of retinoblastoma patients.
    Shehata HH; Abou Ghalia AH; Elsayed EK; Ahmed Said AM; Mahmoud SS
    J AAPOS; 2016 Oct; 20(5):444.e1-444.e9. PubMed ID: 27663628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenascin-C Orchestrates Glioblastoma Angiogenesis by Modulation of Pro- and Anti-angiogenic Signaling.
    Rupp T; Langlois B; Koczorowska MM; Radwanska A; Sun Z; Hussenet T; Lefebvre O; Murdamoothoo D; Arnold C; Klein A; Biniossek ML; Hyenne V; Naudin E; Velazquez-Quesada I; Schilling O; Van Obberghen-Schilling E; Orend G
    Cell Rep; 2016 Dec; 17(10):2607-2619. PubMed ID: 27926865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape.
    Kiliç T; Bayri Y; Ozduman K; Acar M; Diren S; Kurtkaya O; Ekinci G; Buğra K; Sav A; Ozek MM; Pamir MN
    Neurosurgery; 2002 Jul; 51(1):183-92; discussion 192-3. PubMed ID: 12182416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5β1 by the Tenascin-C-Derived Peptide TNIIIA2.
    Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Sasada M; Nagai R; Kudo C; Otsuka K; Kamiya S; Kodama H; Fukai F
    Mol Cancer Ther; 2019 Sep; 18(9):1649-1658. PubMed ID: 31189613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.